Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ratio of Angiogenesis-related Biomarkers (sFlt-1/PlGF) in the Prediction Of mateRnal & feTal outcomeS

NCT03801447 is registered in ClinicalTrials.gov with Dacima Consulting as lead sponsor.

NCT NCT03801447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03801447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ratio of Angiogenesis-related Biomarkers (sFlt-1/PlGF) in the Prediction Of mateRnal & feTal outcomeS
Lead sponsor
Dacima Consulting
Phase
Observational
Overall status
Completed
Start date
April 1, 2018
Completion date
June 30, 2022
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia